Immuneering Corporation (IMRX) Profit Margin
Immuneering Corporation (IMRX) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | -1612.33% |
| 2022-12-31 | -15937.29% |
| 2023-12-31 | -36146.57% |
| 2024-12-31 | -317899.00% |
| 2025-12-31 | N/A |
How IMRX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| PLSE | Pulse Biosciences Inc | -20794.57% |
| BNTC | Benitec Biopharma Inc. | -26082.67% |
| INMB | INmune Bio Inc. | -91800.00% |
| INO | Inovio Pharmaceuticals Inc. | -130000.00% |
| ALT | Altimmune Inc. | -214860.98% |
These are five companies in the same sector as IMRX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Immuneering Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("IMRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IMRX | $4.75 | +4.97% | 0.81M |
| 3 | ||||
| 4 | ||||
| 5 |